Showing results (151-160 of 1,009) with videos related to

Sort By:
Pageof 101
Cancer Research Communications|September 20, 2024
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial ApoptosisKranthi Kumar Chougoni, Victoria Neely, Boxiao Ding, et al.
Cancer Research Communications|September 18, 2024
Peroxisome Proliferator-Activated Receptor δ Suppresses the Cytotoxicity of CD8+ T Cells by Inhibiting RelA DNA-Binding ActivityBo Cen, Jie Wei, Dingzhi Wang, et al.
Cancer Research Communications|October 2, 2024
USP36 SUMOylates Las1L and Promotes Its Function in Pre-Ribosomal RNA ITS2 ProcessingYanping Li, Yunhan Yang, Rosalie C Sears, et al.
Cancer Research Communications|September 11, 2024
PELP1 Is a Novel Therapeutic Target in Hepatocellular CarcinomaKhaled Mohamed Nassar, Xue Yang, Adriana Baker, et al.
Cancer Research Communications|February 29, 2024
Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2M Teresa Ciudad, Rene Quevedo, Sara Lamorte, et al.
Cancer Research Communications|March 7, 2024
Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 ExpressionLyndsey S Crump, Jessica L Floyd, Li-Wei Kuo, et al.
Cancer Research Communications|February 23, 2024
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and AdherenceLaura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Cancer Research Communications|February 21, 2024
Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung CancerShintaro Kinoshita, Midori Ishii, Jun Ando, et al.
Cancer Research Communications|February 15, 2024
Inhibition of Aurora Kinase Induces Endogenous Retroelements to Induce a Type I/III IFN Response via RIG-ILisa Choy, Stephen Norris, Xiumin Wu, et al.
Cancer Research Communications|October 25, 2023
Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate CancerRuiliang Wang, Qiufan Xu, Hanxu Guo, et al.
Pageof 101